Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Bril

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|June 30, 2026
The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASHCaichen Zhong, Nana Boame, Semiu O Gbadamosi, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 13, 2016
Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetesFernando Bril, Sushma Kadiyala, Paola Portillo Sanchez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2015
Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patientsFernando Bril, Carolina Ortiz-Lopez, Romina Lomonaco, et al.
Diabetes Care|February 11, 2016
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 DiabetesRomina Lomonaco, Fernando Bril, Paola Portillo-Sanchez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2021
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASHAmalia Gastaldelli, Silvia Sabatini, Fabrizia Carli, et al.
The British Journal of Nutrition|July 13, 2026
Effects of a low-glycemic, moderately-carbohydrate restricted diet on hepatic lipid content and insulin sensitivity in adolescents with MASLD: protocol of a 6-month family-based, randomized controlled trialCarly E Drake, Barbara Gower, Ambika Ashraf, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2025
Approach to the Patient: HirsutismRicardo Azziz, Mina Amiri, Fernando Bril, et al.
Hepatology (Baltimore, Md.)|December 17, 2016
Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver diseaseFernando Bril, Diana Barb, Paola Portillo-Sanchez, et al.
Diabetes, Obesity & Metabolism|March 13, 2018
Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitusFernando Bril, Laura Millán, Srilaxmi Kalavalapalli, et al.
Diabetes Care|July 24, 2019
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled TrialFernando Bril, Diane M Biernacki, Srilaxmi Kalavalapalli, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Expert Review of Pharmacoeconomics & Outcomes Research|June 30, 2026
The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASHCaichen Zhong, Nana Boame, Semiu O Gbadamosi, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 13, 2016
Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetesFernando Bril, Sushma Kadiyala, Paola Portillo Sanchez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2015
Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patientsFernando Bril, Carolina Ortiz-Lopez, Romina Lomonaco, et al.
Diabetes Care|February 11, 2016
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 DiabetesRomina Lomonaco, Fernando Bril, Paola Portillo-Sanchez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2021
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASHAmalia Gastaldelli, Silvia Sabatini, Fabrizia Carli, et al.
The British Journal of Nutrition|July 13, 2026
Effects of a low-glycemic, moderately-carbohydrate restricted diet on hepatic lipid content and insulin sensitivity in adolescents with MASLD: protocol of a 6-month family-based, randomized controlled trialCarly E Drake, Barbara Gower, Ambika Ashraf, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2025
Approach to the Patient: HirsutismRicardo Azziz, Mina Amiri, Fernando Bril, et al.
Hepatology (Baltimore, Md.)|December 17, 2016
Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver diseaseFernando Bril, Diana Barb, Paola Portillo-Sanchez, et al.
Diabetes, Obesity & Metabolism|March 13, 2018
Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitusFernando Bril, Laura Millán, Srilaxmi Kalavalapalli, et al.
Diabetes Care|July 24, 2019
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled TrialFernando Bril, Diane M Biernacki, Srilaxmi Kalavalapalli, et al.
Pageof 11